These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 19850631)

  • 21. Tandem mass spectrometric determination of succinylacetone in dried blood spots enables presymptomatic detection in a case of hepatorenal tyrosinaemia.
    Weigel JF; Janzen N; Pfäffle RW; Thiery J; Kiess W; Ceglarek U
    J Inherit Metab Dis; 2007 Aug; 30(4):610. PubMed ID: 17694358
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Spectrophotometric microassay for delta-aminolevulinate dehydratase in dried-blood spots as confirmation for hereditary tyrosinemia type I.
    Schulze A; Frommhold D; Hoffmann GF; Mayatepek E
    Clin Chem; 2001 Aug; 47(8):1424-9. PubMed ID: 11468232
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Development of Flow Injection Analysis Method for the Second-Tier Estimation of Succinylacetone in Dried Blood Spot of Newborn Screening.
    Varughese B; Madrewar D; Polipalli SK; Kapoor S
    Indian J Clin Biochem; 2022 Jan; 37(1):40-50. PubMed ID: 35125692
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Proficiency testing outcomes of 3-hydroxyisovalerylcarnitine measurements by tandem mass spectrometry in newborn screening.
    Lim TH; De Jesús VR; Meredith NK; Sternberg MR; Chace DH; Mei JV; Hannon WH
    Clin Chim Acta; 2011 Mar; 412(7-8):631-5. PubMed ID: 21185274
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Development and characterization of dried blood spot materials for the measurement of immunoreactive trypsinogen.
    Li L; Zhou Y; Bell CJ; Earley MC; Hannon WH; Mei JV
    J Med Screen; 2006; 13(2):79-84. PubMed ID: 16792830
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Enhancing newborn screening for tyrosinemia type I.
    Pass KA; Morrissey M
    Clin Chem; 2008 Apr; 54(4):627-9. PubMed ID: 18375485
    [No Abstract]   [Full Text] [Related]  

  • 27. Evaluation of factors influencing accuracy in the analysis of succinylacetone in dried blood spots.
    Peng M; Liu L; Peng L
    Clin Chim Acta; 2012 Aug; 413(15-16):1265-9. PubMed ID: 22522056
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Significant increase of succinylacetone within the first 12 h of life in hereditary tyrosinemia type 1.
    Schlump JU; Mayatepek E; Spiekerkoetter U
    Eur J Pediatr; 2010 May; 169(5):569-72. PubMed ID: 19813022
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Clinical utilization of dried blood spot nitisinone (NTBC) and succinylacetone (SA) concentrations in hereditary tyrosinaemia type 1 - A UK centre experience.
    Yeo M; Turner C; Dalton NR; Rahman Y; Vara R
    Ann Clin Biochem; 2020 Nov; 57(6):412-419. PubMed ID: 32936663
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Newborn Screening for Hereditary Tyrosinemia Type I in Québec: Update.
    Giguère Y; Berthier MT
    Adv Exp Med Biol; 2017; 959():139-146. PubMed ID: 28755192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Silent Tyrosinemia Type I Without Elevated Tyrosine or Succinylacetone Associated with Liver Cirrhosis and Hepatocellular Carcinoma.
    Blackburn PR; Hickey RD; Nace RA; Giama NH; Kraft DL; Bordner AJ; Chaiteerakij R; McCormick JB; Radulovic M; Graham RP; Torbenson MS; Tortorelli S; Scott CR; Lindor NM; Milliner DS; Oglesbee D; Al-Qabandi W; Grompe M; Gavrilov DK; El-Youssef M; Clark KJ; Atwal PS; Roberts LR; Klee EW; Ekker SC
    Hum Mutat; 2016 Oct; 37(10):1097-105. PubMed ID: 27397503
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Newborn Screening for Tyrosinemia Type I: Further Evidence that Succinylacetone Determination on Blood Spot Is Essential.
    la Marca G; Malvagia S; Pasquini E; Cavicchi C; Morrone A; Ciani F; Funghini S; Villanelli F; Zammarchi E; Guerrini R
    JIMD Rep; 2011; 1():107-9. PubMed ID: 23430836
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Identification of a neonate with hepatorenal tyrosinemia by combined routine newborn screening for succinylacetone, acylcarnitines and amino acids.
    Al-Dirbashi OY; Fisher L; McRoberts C; Siriwardena K; Geraghty M; Chakraborty P
    Clin Biochem; 2010 May; 43(7-8):691-3. PubMed ID: 19836366
    [No Abstract]   [Full Text] [Related]  

  • 34. Effect of blood volume on analytical bias in dried blood spots prepared for newborn screening external quality assurance.
    Moat SJ; Dibden C; Tetlow L; Griffith C; Chilcott J; George R; Hamilton L; Wu TH; MacKenzie F; Hall SK
    Bioanalysis; 2020 Jan; 12(2):99-109. PubMed ID: 31854202
    [No Abstract]   [Full Text] [Related]  

  • 35. Tyrosinemia type 1: an overview of nursing care.
    Barnby E
    Pediatr Nurs; 2014; 40(2):61-8, 90. PubMed ID: 24941508
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The inclusion of ADA-SCID in expanded newborn screening by tandem mass spectrometry.
    la Marca G; Giocaliere E; Malvagia S; Funghini S; Ombrone D; Della Bona ML; Canessa C; Lippi F; Romano F; Guerrini R; Resti M; Azzari C
    J Pharm Biomed Anal; 2014 Jan; 88():201-6. PubMed ID: 24076575
    [TBL] [Abstract][Full Text] [Related]  

  • 37. A computer vision approach to the assessment of dried blood spot size and quality in newborn screening.
    Flynn N; Moat SJ; Hogg SL
    Clin Chim Acta; 2023 Jul; 547():117418. PubMed ID: 37276944
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hepatorenal Tyrosinemia in Mexico: A Call to Action.
    Ibarra-González I; Ridaura-Sanz C; Fernández-Lainez C; Guillén-López S; Belmont-Martínez L; Vela-Amieva M
    Adv Exp Med Biol; 2017; 959():147-156. PubMed ID: 28755193
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Storage and use of residual dried blood spots from state newborn screening programs.
    Olney RS; Moore CA; Ojodu JA; Lindegren ML; Hannon WH
    J Pediatr; 2006 May; 148(5):618-22. PubMed ID: 16737872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Analysis of succinylacetone, as a Girard T derivative, in urine and dried bloodspots by flow injection electrospray ionization tandem mass spectrometry.
    Johnson DW; Gerace R; Ranieri E; Trinh MU; Fingerhut R
    Rapid Commun Mass Spectrom; 2007; 21(1):59-63. PubMed ID: 17133337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.